Preparation and initial characterization of inclusion complex between nitrofurazone and 2-hydroxypropyl-β-cyclodextrin;Preparação e caracterização inicial de complexo de inclusão entre nitrofurazona e 2-hidroxipropil-β-ciclodextrina

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 28, Issue 1, 2007, Pages 35-44

  Melo, N F S ^a   Grillo, R ^a   Moraes, C M ^b   Brito, C L ^c   Trossini, G H G ^c   Menezes, C M S ^c   Ferreira, E I ^c   Rosa, A H ^a   Fraceto, Leonardo Fernandes ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cyclodextrin; Inclusion complex; Nitrofurazone

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; NITROFURAL;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTHERM; PHOTODEGRADATION; SCANNING ELECTRON MICROSCOPY; STOICHIOMETRY; TEMPERATURE;

EID: 39549087442     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12:413-20.
2. Araújo DR, Pinto LMA, Braga AFA, de Paula E. Drug-delivery systems for local anesthetics:therapeutic applications. Rev Bras Anestesiol 2003; 53:663-71.
3. Azevedo MBM, Alderete JB, Rodriguez JA, Souza AO, Rettori D, Torsoni MA, Faljoni-Alario A, Haun M, Duran N. Biological activities of violacein, a new antitumoral indole derivative, in an inclusion complex with β-Cyclodextrin. J Incl Phenom Macrocycl Chem 2000; 37:93-101.
4. Bayomi MB, Abanumay KA, Al-Angary AA. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Int J Pharm 2002; 243:107-17.
5. Bekers O, Uijtendaal EV, Beijnen JH, Bult A, Underberg WJM. Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 1991; 17:1503-49.
6. Chen CC, Chen FA, Wu A, Hsu H, Kang J, Cheng H. Effect of hydroxypropyl-β-cyclodextrin on the solubility, photostability and in-vitro permeability of alkannin/shikonin enantiomers. Int J Pharm 1996; 141:171-8.
7. Connors KA. The stability of cyclodextrin complexes in solution. Chem Rev 1997; 97:1325-58.
8. Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004; 39:1033-46.
9. Dodd MC, Stillman WB. The in vitro bacteriostatic action of some simple furan derivatives. J Pharmacol Exp Ther 1944; 82:11-8.
10. Etos S, Noda H, Noda A. J. Simultaneous determination of antiepileptic drugs and their metabolites, including chiral compounds, via beta-cyclodextrin inclusion complexes by a column-switching chromatographic technique. J Chromatogr B 1994; 19:385-90.
11. Flood KG, Reynolds ER, Snow NH. Characterization of inclusion complexes of betamethasone-related steroids with cyclodextrins using high-performance liquid chromatography. J Chromatogr A 2000; 903:49-65.
12. Gonçalves MF, Chung MC, Colli W, Miranda MTM, Ferreira EI. Efeito da associação da nitrofurazona e primaquina em células LLC-MK2 infectadas com formas tripomastigotas de Trypanossoma cruzi. Rev Soc Bras Med Trop 1994; 27:164.
13. Henderson GB, Ulrich P, Fairlamb AH, Rosemberg I, Pereira M, Sela M, Cerami A. "Subversive" substrates for the enzyme trypanothione disulphide reductase, alternative approach to chemoterapy of Chagas disease. Proc Natl Acad Sci 1988; 85:5374-8.
14. Irie T, Uekama K. Pharmaceutical applications of ciclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997; 86:147-62.
15. Ivanov PM, Salvatierra D, Jaime C. Experimental (NMR) and Computational (MD) Studies on the Inclusion Complexes of 1-Bromoadamantane with alpha-, beta-, and gamma-Cyclodextrin. J Org Chem 1996, 61:7012-7.
16. Laverde Jr A, Conceição GJA, Queiroz SCN, Fujiwara FY, Marsaioli AJ. An NMR tool for cyclodextrin selection in enantiomeric resolution by high-performance liquid. Magn Reson Chem 2002; 40:433-42.
17. Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm 2001; 225:15-30.
18. Loukas YL, Vraka V, Gregoriadis G. Drugs in cyclodextrins, in liposomes: a novel approach to the chemical stability of drugs sensitive to hydrolysis. Int J Pharm 1998; 162(2):137-42.
19. Másson M, Loftsson T, Másson G, Stefánsson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release 1999; 59(1):107-18.
20. Matioli G. Ciclodextrinas e suas aplicações em alimentos, fârmacos, agricultura, biotecnologia, química analítica e produtos gerais. Maringá: Eduem Editora; 2000. 124p.
21. McCormack B, Gregoriadis G. Drugs-in-cyclodextrins-inliposomes: an approach to controlling the fate of water insoluble drugs in vivo. Int J Pharm 1998;162:59-69.
22. Mielcarek J, Daczkowska E. Photodegradation of inclusion complexes of isradipine with methyl-beta-cyclodextrin. J Pharm Biomed Anal 1999; 21(2):393-8.
23. Mielcarek J. Effect of hydroxypropyl-β-cyclodextrin on the solubility, photostability and in-vitro permeability of alkannin/shikonin enantiomers. Int J Pharm 1994; 141:171-8.
24. Moraes CM, Abrami P, Gonçalves MM, Andreo-Filho N, Fernandes SA, de Paula E, Fraceto LF. Preparação e caracterização físico-química de complexos de inclusão entre anestésicos locais e hidroxipropil - ciclodextrina. Quím Nova 2007, 30:777-84.
25. Morin N, Guillaume YC, Peyrin E, Rouland JC. Peculiarities of an imidazole derivative retention mechanism in reversed-phase liquid chromatography: β-cyclodextrin concentration and temperature considerations. J Chromatogr A 1998; 808:51-60.
26. Nichols W. Antiinfecciosos In: Gennaro, AR. (Ed.) Remington: a ciência e a prática da farmácia. Rio de Janeiro: Guanabara Koogan; 2004.
27. Paavola A, Yliruusi J, Kajimoto Y, Kalso E, Wahlström T, Rosenberg P. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res 1995; 12:1997-2002.
28. Pinto LMA, Fraceto LF, Santana MH, Pertinhez TA, Oyama-Junior S, de Paula E. Physico-chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes. J Pharm Biomed Anal 2005, 39:956-63.
29. Pomponio R, Gotti R, Fiori J, Cavrini V, Mura P, Cirri M, Maestrelli F. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2003; 244:127-35.
30. Race PR, Lovering AL, Green RM, Ossor A, White SA, Searle PF, Wrighton CJ, Hyde ELJ. Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme. J Biol Chem 2005; 280:13256-64.
31. Stalcup AM, Chang SS, Armstrong DW, Pitha, JJ. (S)-2-hydroxypropyl-beta- cyclodextrin, a new chiral stationary phase for reversed-phase liquid chromatography. J Chromatogr A 1990;513:181-94.
32. Thomas G. Solubilidade dos fármacos. In: Química medicinal: uma introdução. Rio de Janeiro: Guanabara Koogan; 2003. 345p.
33. Tong WQ, Lach JL, Chin TF, Guillory JK. Microcalorimetric investigation of the complexation between 2-hydroxypropyl-beta-cyclodextrin and amine drugs with the diphenylmethyl functionality. J Pharm Biomed Anal 1991; 9:1139-46.
34. Yap KL, Liu X, Thenmozhiyal JC, Ho PC. Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. J Pharm Biomed Anal 2004; 35:267-75.